Physician profile
Peter Coreless Anderson
NPI 1043444516
$3,740.47
in general payments reported to CMS, 2019-2025
11 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,533 · 2020: $17.19 · 2021: $54.55 · 2022: $34.91 · 2024: $885 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $701 · Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $700.60 |
| Food and Beverage | $400.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,554.61 | 2019-2021 | |
| Stryker Corporation | $931.24 | 2019-2025 | Scopis Ent, Xpress Loprofile |
| Optinose US, INC. | $66.61 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $51.72 | 2024-2025 | Dupixent |
| Abbvie INC. | $34.50 | 2025 | |
| Cochlear Americas | $23.40 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $17.71 | 2024 | Nucala |
| Aerin Medical INC. | $17.51 | 2022 | |
| Pfizer INC. | $15.39 | 2025 | |
| Boston Scientific Corporation | $14.52 | 2021 | |
| Medtronic, INC. | $13.26 | 2024 | Stealthstation S8 Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.